Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01647321 |
Recruitment Status
:
Recruiting
First Posted
: July 23, 2012
Last Update Posted
: August 30, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Secondary Progressive Multiple Sclerosis | Behavioral: Active cycling Behavioral: Passive cycling | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Evaluating the Effects of Functional Electrical Stimulation on Ambulation in Individuals With Secondary Progressive Multiple Sclerosis |
Actual Study Start Date : | July 2012 |
Estimated Primary Completion Date : | June 2019 |
Estimated Study Completion Date : | June 2020 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Active cycling
Individuals will receive functional electrical stimulation while on the stationary bike and instructed to actively pedal.
|
Behavioral: Active cycling
The exercise program uses a stationary bike equipped with functional electrical stimulation (FES) of leg muscles. Participants are instructed to actively pedal while the FES is assisting. The training program is expected to be performed for one hour, three times a week for 12 weeks.
Other Names:
|
Sham Comparator: Passive cycling
Individuals will receive active functional electrical stimulation (FES) while on the stationary bike and instructed to relax their legs, allowing the FES to move their legs on the stationary bike.
|
Behavioral: Passive cycling
The exercise program uses a stationary bike equipped with functional electrical stimulation (FES) of leg muscles. Participants are instructed to sit passively on the stationary bile while the FES is assisting. The training program is expected to be performed for one hour, three times a week for 12 weeks.
Other Name: letting the functional electrical stimulation move the legs
|
- Change in timed 25 foot walk from baseline to end of training [ Time Frame: Participants are assessed at baseline (visit 1), one-month (visit 2), two-months (visit 3), three-months (visit 4), end of study (visit 5) ]Here we will assess whether a subjects walking speed is improved following active cycling with functional electrical stimulation. Our prediction is that individuals will improve in their walking function following seated active cycling with functional electrical stimulation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 68 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- clinical diagnosis of secondary progressive multiple sclerosis
- males and females between the ages of 18 and 65 years
- Expanded disability status scale score between 5.0 and 7.0
- Able to consent to participate in study and are willing to undergo a lumbar puncture and blood draws
- If on on Ampyra or anti-spasticity agent, must be on stable dose for 1 month prior to screening
- No functional electrical stimulation use within 4 weeks
- Participants must be medically stable with no recent (1 month or less) inpatient admission for acute medical or surgical issues
Exclusion Criteria:
- Uncontrolled hypertension or other significant cardiovascular disease as determined by investigator
- History of epileptic seizures
- Subjects who have a pacemaker
- Relapse within thirty days prior to screening visit
- Pregnancy
- Subjects having a Stage 2 or greater sacral decubitus ulcer

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01647321
Contact: Sandi Cassard | 443-287-4353 | scassar1@jhmi.edu |
United States, Maryland | |
Johns Hopkins / Kennedy Krieger Institute | Recruiting |
Baltimore, Maryland, United States, 21205 | |
Principal Investigator: S Newsome, MD |
Responsible Party: | Johns Hopkins University |
ClinicalTrials.gov Identifier: | NCT01647321 History of Changes |
Other Study ID Numbers: |
NA_00069253 |
First Posted: | July 23, 2012 Key Record Dates |
Last Update Posted: | August 30, 2017 |
Last Verified: | August 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Keywords provided by Johns Hopkins University:
SPMS |
Additional relevant MeSH terms:
Sclerosis Multiple Sclerosis Neoplasm Metastasis Multiple Sclerosis, Chronic Progressive Pathologic Processes Demyelinating Autoimmune Diseases, CNS Autoimmune Diseases of the Nervous System |
Nervous System Diseases Demyelinating Diseases Autoimmune Diseases Immune System Diseases Neoplastic Processes Neoplasms |